文献速递慢性肾脏病急性肾损伤

肾衰竭综合风险预测:临床与多组学方法

Integrated Risk Prediction of Kidney Failure: Clinical and Multi-Omic Approaches.
PubMed 文献 · Clin J Am Soc Nephrol · 2026-09-29

本研究在非裔美国人中评估多基因风险评分(PRS)和甲基化风险评分(MRS)对肾衰竭的预测能力,并与肾衰竭风险方程(KFRE)比较。结果显示PRS和MRS与 incident 肾衰竭相关,但KFRE作为单一预测因子表现更优;联合模型提示PRS和MRS可协同提升KFRE的预测准确性。

要点

  • PRS和MRS与肾衰竭风险相关,但预测能力不及KFRE。
  • PRS和MRS与肾功能下降速率无关。
  • 联合KFRE、PRS和MRS可识别最高风险人群。

核心结论

  • PRS和MRS可能不优于临床算法,但纳入组学信息可改善疾病风险预测。

研究设计与样本

  • 利用HyperGEN、MESA和eMERGE网络中非裔美国人参与者的基因组、表观基因组和临床数据,评估PRS和MRS预测肾衰竭和肾功能下降的能力,并与KFRE比较。

主要发现

  • 在HyperGEN中,较高的PRS与较高的肾衰竭风险相关。
  • 在HyperGEN和MESA中,MRS与 incident 肾衰竭相关。
  • 在eMERGE或MESA中,PRS和MRS均与肾功能下降速率无关。
  • KFRE作为单一预测因子优于PRS和MRS。
  • 多评分模型提示PRS和MRS对KFRE预测准确性有协同效应,KFRE、PRS和MRS均属高风险层级的个体肾衰竭风险最高。

临床怎么用

  • 临床可继续使用KFRE进行肾衰竭风险预测,组学评分联合KFRE可能进一步优化风险分层。

局限性

  • 探索性分析,样本量有限,需未来扩大样本量以更好评估风险模型并提升其能力。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Kidney failure affects approximately 800,000 adults in the United States, and African Americans carry a disproportionate burden of disease. Robust algorithms for clinical risk prediction, such as the Kidney Failure Risk Equation (KFRE), have previously been validated, whereas the clinical utility of polygenic (PRS) and methylation risk scores (MRS), have not been as well characterized.1. METHODS: In this study, we evaluated the capacity of PRS and MRS for CKD to predict multiple clinical endpoints, including incident kidney failure and decline in kidney function. Leveraging genomic, epigenomic, and clinical data from African American participants of the Hypertension Genetic Epidemiology Network (HyperGEN), Multi-Ethnic Study of Atherosclerosis (MESA), and Electronic Medical Records and Genomics (eMERGE) Network, we evaluated the performance of these risk scores in comparison to and in conjunction with the widely validated KFRE. RESULTS: In HyperGEN, a higher PRS was associated with a higher risk of kidney failure. Similarly, the MRS was associated with incident kidney failure in both HyperGEN and MESA. Neither PRS nor MRS were associated with the rate of decline in kidney function in eMERGE or MESA. The KFRE outperformed both PRS and MRS as a single predictor. However, multi-score models suggested a synergistic effect of PRS and MRS to the predictive accuracy of the KFRE, with the greatest risk of kidney failure among individuals in high-risk strata of KFRE, PRS, and MRS. CONCLUSIONS: Results from this exploratory analysis suggest that, while PRS and MRS may not be superior to clinical algorithms, inclusion of '-omics' information may improve disease risk prediction. Future studies should seek to increase sample size to better evaluate these risk models and improve their capacity.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Jones AC, Khan A, Patki A, et al. Integrated Risk Prediction of Kidney Failure: Clinical and Multi-Omic Approaches. Clin J Am Soc Nephrol. 2026. PMID: 42809347. doi:10.2215/CJN.0000001217

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。